Navigation Links
Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
Date:11/5/2009

ve (617) 576-5788 amyp@waggeneredstrom.com

TRBN-G

    (Tables Follow)



                                TRUBION PHARMACEUTICALS. INC.
                                   STATEMENTS OF OPERATIONS
                             (In thousands, except per share data)
                                       (unaudited)

                            Three months ended      Nine months ended
                               September 30,           September 30,
                             -----------------       -----------------
                              2009      2008         2009         2008
                              ----      ----         ----         ----

    Revenue                  $4,452   $3,766       $12,783      $12,197

    Operating expenses:
      Research and
       development            7,410    7,397        27,587       23,302
      General and
       administrative         3,146    2,987         8,877        8,985
                              -----    -----         -----        -----
        Total operating
         expenses            10,556   10,384        36,464       32,287
                             ------   ------        ------       ------
    Loss from
     operations              (6,104)  (6,618)      (23,681)     (20,090)
      Interest income             8      370           162        1,585
      Interest expense         (131)    (334)         (409)        (677)
                               ----     ----          ----         ----
    Net loss                $(6,227) $(6,582)     $(23,928)    $(19,182)
                            =======  =======      ========     ========

    Basic and diluted
     net loss per share      $(0.33)  $(0.37)       $(1.31)      $(1.07)
                             ======   ======        ======       ======

      Shares used in
       computation of basic
       and diluted n
'/>"/>
SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
2. Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
3. Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
4. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
5. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
6. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
7. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
8. Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
9. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
10. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
11. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  Perrigo Company plc ("Perrigo") (NYSE: ... of "Quality Affordable Healthcare Products®," today announced the closing ... the sale of 6,809,210 ordinary shares at a public ... exercise of the option to purchase up to an ... and Barclays Capital Inc., as representatives of the several ...
(Date:11/26/2014)... , Nov. 26, 2014  Genomic Health, Inc. (Nasdaq: ... , Chairman, Chief Executive Officer and President, will participate ... Conference at The New York Palace Hotel in ... at 11:30 am Eastern Time (ET). To ... conference call, go to the  Investor Relations  section of ...
(Date:11/26/2014)... 2014   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... CEO of Regulus, will present a company overview at ... at the New York Palace Hotel on Wednesday, December ... be webcast at the time of the presentation and ...
Breaking Medicine Technology:Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “LAB.C” was ... which features the latest and coolest technology products available to ... conducted the product review and shared with viewers ... for iOS and Android devices. , Consumers love portability and ... Their Cable Case for the iPhone5 and 5S has ...
(Date:11/27/2014)... This is a professional and ... For an overview analysis, the report introduces Insulin ... structure, industry overview, policy analysis, and news analysis, ... covers information on policy, plans for Insulin Market ... much more. , This report also ...
(Date:11/27/2014)... Allowing children to help with chores while ... give children responsibility, ownership, boosts self-esteem, and above all, helps ... the real question is, how do you encourage your children ... a study published by Child Development Journal, there is. The ... on a child’s willingness to lend a hand. , ...
(Date:11/27/2014)... 27, 2014 RBSEO Services, a ... engine optimization service just at $99. RBSEO Services ... cannot afford costly search engine optimization service. So, ... their affordablity and requirements into consideration. , ... it has not compromised with the service quality. ...
(Date:11/27/2014)... Ethane Web Technologies, an ISO 9001: 2008 certified Internet ... discount on PPC service. The discount will be available for ... on 1 December 2014 and remain valid until midnight of ... professional working at Ethane Web Technologies says, "This is a ... big discount would make the service quite affordable for them. ...
Breaking Medicine News(10 mins):Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:RBSEO Services Announces SEO Services at $99 Only 2Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2
... Researchers aren,t sure why two conditions are connected , WEDNESDAY, ... likely to have heart attacks, a new study shows, but ... still unclear. , The incidence of heart attacks in people ... suffer the headaches, according to a report in the Feb. ...
... quarter of Ontario hospitals surveyed in a Queen,s University-led study ... that do exist have been tested. In addition, key players ... pandemic preparedness was inadequate., "It,s not good enough just to ... to know how well it will work in an emergency," ...
... DES PLAINES, Ill. , Feb. 10 ... for the ENA Leadership Conference to be held in ... All of ENA,s sponsors will be recognized at the upcoming ... Monster.com and Stryker; the Leadership Conference Sponsor, Physio-Control; and the ...
... , ... - Hiru Corporation (HIRU; www.hirucorporation.com ) and its European subsidiary ... about the MindUp and Sabera Ruzdijic,s patents. Dr. Sabera Ruzdijic ... cancer project. The other team leaders in MindUp Research project are ...
... February 10, 2010 The American Society ... as part of its program specifically dedicated to promoting ... practiced in the United States. The ASGE Endoscopy Unit ... guidelines on privileging, quality assurance, endoscopy reprocessing and CDC ...
... ... on celiac disease, one of the most common and under-diagnosed autoimmune diseases, it,s symptoms, and ... patients a year, one being day-time Emmy Award winner, Elisabeth Hasselbeck of ABC’s “The View”. ... (PRWEB) February 11, 2010 ...
Cached Medicine News:Health News:Migraine Linked to Increased Heart Attack Risk 2Health News:Migraine Linked to Increased Heart Attack Risk 3Health News:Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference 2Health News:Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference 3Health News:MindUp (HIRU) Patents in the World Patent Database 2Health News:MindUp (HIRU) Patents in the World Patent Database 3Health News:ASGE recognizes 32 endoscopy units for quality and safety 2Health News:Multi-Award Winning Author Tina Turbin Interviews Special Guest Dr. Peter H.R. Green, M.D. On The Thrive in Balance Radio Show 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: